You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tucidinostat

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteosarcoma Trial (Tucidinostat, Apatinib)

Not yet recruiting
  • Osteosarcoma
  • Tucidinostat, Apatinib
  • (no location specified)
Nov 5, 2023

HR+/HER2- Breast Cancer Trial (Tucidinostat, nab-paclitaxel)

Not yet recruiting
  • HR+/HER2- Breast Cancer
  • (no location specified)
Nov 21, 2022

Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)

Recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-yat sen university cancer center
Nov 1, 2022

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Neuroblastoma in Children Trial in Guangzhou (Tucidinostat and etoposide)

Recruiting
  • Neuroblastoma in Children
  • Tucidinostat and etoposide
  • Guangzhou, China
    Sun Yat-sen University
Jun 9, 2022

Breast Cancer Trial in Guangzhou (Tucidinostat, Capecitabine, Endocrine Therapy)

Recruiting
  • Breast Cancer
  • Tucidinostat
  • +2 more
  • Guangzhou, Gangdong, China
    Shusen Wang
Nov 1, 2022

HER2 Negative Breast Cancer Trial in Zhenzhou (Eribulin plus Tucidinostat)

Not yet recruiting
  • HER2 Negative Breast Cancer
  • Eribulin plus Tucidinostat
  • Zhenzhou, China
    Henan Cancer Hospital
May 26, 2022

HR+ Metastatic Breast Cancer Patients Previously Treated With

Recruiting
  • Breast Cancer
  • Tucidinostat
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA General Hospital
Mar 3, 2022

T-cell Lymphoma Trial (Tucidinostat, Azacitidine combined with CHOP)

Not yet recruiting
  • T-cell Lymphoma
  • Tucidinostat, Azacitidine combined with CHOP
  • (no location specified)
Oct 9, 2021

Breast Cancer Trial (Tucidinostat, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 7, 2021

DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

Diffuse Large B-cell Lymphoma Trial in Beijing, Shanghai (R-CHOP(Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and

Recruiting
  • Diffuse Large B-cell Lymphoma
  • R-CHOP(Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone)
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Aug 8, 2021

Peripheral T Cell Lymphoma Trial in Shanghai (Azacitidine Injection, Dasatinib, Linperlisib)

Recruiting
  • Peripheral T Cell Lymphoma
  • Azacitidine Injection
  • +6 more
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Nov 8, 2022

Triple Negative Breast Cancer Trial in Guangzhou (Chidamide combined with Zimberelimab)

Recruiting
  • Triple Negative Breast Cancer
  • Chidamide combined with Zimberelimab
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Nov 20, 2022

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Relapsed or Refractory Peripheral T-cell Lymphoma Trial in Taiwan (Chidamide)

Not yet recruiting
  • Relapsed or Refractory Peripheral T-cell Lymphoma
  • Kaohsiung, Taiwan
  • +4 more
Apr 17, 2023

Non Small Cell Lung Cancer Trial in United States (HBI-8000 in combination with pembrolizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • HBI-8000 in combination with pembrolizumab
  • Goodyear, Arizona
  • +6 more
Dec 5, 2022

Metastatic Colorectal Cancer Trial in New Taipei City (chidamide, celecoxib)

Recruiting
  • Metastatic Colorectal Cancer
  • New Taipei City, Taiwan
    Taipei Medical University Shuang Ho Hospital
Mar 4, 2022

Breast Cancer Trial in Guangzhou (Tucidinostat, Exemestane, Ovarian function suppression)

Unknown status
  • Breast Cancer
  • Tucidinostat
  • +2 more
  • Guangzhou, Guangdong, China
    The first affiliated hospital of Sun Yat-Sen university
Jul 22, 2020

Diffuse Large B-cell Lymphoma Trial in Changchun (Tucidinostat)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Tucidinostat
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Dec 4, 2020